美国Cepheid 
总部位于美国加州Sunnyvale的美国Cepheid公司(纳斯达克交易代码:CPHD)是一个致力于研发、生产和应用的分子诊断厂家；是致力于在临床、工业和生物威胁领域开发完全整合的快速、准确、便捷的检测系统，例如：在临床领域中的传染病和癌症的诊断，工业领域中食品、农业和环境的检测，生物威胁领域中生物恐怖因子的鉴定识别。

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.